Список литературы

Поставить закладку

Anderson K.E. et al. Recommendations for the diagnosis and treatment of the acute porphyrias // Annals of Internal Medicine. American College of Physicians, 2005. Vol. 142, № 6. P. 439–450.
Kauppinen R. Porphyrias // Lancet. 2005. Vol. 365, № 9455. P. 241–252.
Yasuda M., Chen B., Desnick R.J. Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes // Molecular Genetics and Metabolism. Academic Press Inc., 2019. Vol. 128, № 3. P. 320–331.
Pischik E., Kauppinen R. An update of clinical management of acute intermittent porphyria // Application of Clinical Genetics. Dove Medical Press Ltd., 2015. Vol. 8. P. 201–214.
Pischik E., Kauppinen R. Neurological manifestations of acute intermittent porphyria // Cell Mol Biol (Noisy-le-grand). 2009. Vol. 55, № 1. P. 72–83.
Пустовойт Я.С. Г.Г.М., С.В.Г. Диагностическая роль отдельных синдромов и симптомов в семиотике острых порфирий // Гематология и трансфузиология. 2014. Vol. 3. P. 35–39.
Pischik E., Kazakov V., Kauppinen R. Is screening for urinary porphobilinogen useful among patients with acute polyneuropathy or encephalopathy? // J Neurol. J Neurol, 2008. Vol. 255, № 7. P. 974–979.
Balwani M. et al. Acute hepatic porphyrias: Recommendations for evaluation and long-term management // Hepatology. John Wiley and Sons Inc., 2017. Vol. 66, № 4. P. 1314–1322.
Stein P. et al. Best practice guidelines on clinical management of acute attacks of porphyria and their complications // Ann Clin Biochem. Ann Clin Biochem, 2013. Vol. 50, № 3. P. 217–223.
Пустовойт Я.С. и др. Российский реестр лекарственных препаратов, применяемых у больных с нарушениями порфиринового обмена // Гематология и трансфузилогия. 2015. Vol. 60. P. 38–43.
Goldberg A. ACUTE INTERMITTENT PORPHYRIA: A Study of 50 Cases // QJM: An International Journal of Medicine. Oxford Academic, 1959. Vol. 28, № 2. P. 183–209.
Stein J.A., Tschudy D.P. Acute intermittent porphyria. A clinical and biochemical study of 46 patients // Medicine (Baltimore). 1970. Vol. 49, № 1. P. 1–16.
WALDENSTROM J. NEUROLOGICAL SYMPTOMS CAUSED BY SOCALLED ACUTE PORPHYRIA // Acta Psychiatr Scand. John Wiley & Sons, Ltd, 1939. Vol. 14, № 1–2. P. 375–379.
Ridley A. The neuropathy of acute intermittent porphyria // Q J Med. 1969. Vol. 38, № 151. P. 307–333.
Zheng X. et al. Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: Two case reports and a literature review // Medicine (United States). Lippincott Williams and Wilkins, 2018. Vol. 97, № 36.
Kakoullis L. et al. Porphyrias and photosensitivity: pathophysiology for the clinician // Postgraduate Medicine. Taylor and Francis Inc., 2018. Vol. 130, № 8. P. 673–686.
Yrjönen A. et al. A novel 19-bp deletion of exon 15 in the HMBS gene causing acute intermittent porphyria associating with rhabdomyolysis during an acute attack // Clinical Genetics. Clin Genet, 2008. Vol. 74, № 4. P. 396–398.
Balwani M. et al. Acute Intermittent Porphyria in children: A case report and review of the literature // Molecular Genetics and Metabolism. Academic Press Inc., 2016. Vol. 119, № 4. P. 295–299.
Bonkovsky H.L. et al. Acute porphyrias in the USA: Features of 108 subjects from porphyrias consortium // American Journal of Medicine. Elsevier Inc., 2014. Vol. 127, № 12. P. 1233–1241.
Hift R.J., Meissner P.N. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyrio differ in susceptibility and severity // Medicine. Medicine (Baltimore), 2005. Vol. 84, № 1. P. 48–60.
Woolf J. et al. Best practice guidelines on first-line laboratory testing for porphyria // Annals of Clinical Biochemistry. SAGE Publications Ltd, 2017. Vol. 54, № 2. P. 188–198.
Mustajoki P., Nordman Y. Early administration of heme arginate for acute porphyric attacks // Arch Intern Med. 1993. Vol. 153, № 17. P. 2004–2008.
Watson C.J., Schwartz S. A Simple Test for Urinary Porphobilinogen. // Exp Biol Med. SAGE PublicationsSage UK: London, England, 1941. Vol. 47, № 2. P. 393–394.
Kauppinen R., von und zu Frauenberg M. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families // Clin Chem. 2002. Vol. 48, № 11. P. 1891–1900.
Mazzoli M R.A.V.A.M.M.M.S.B.P.D.P.E.P.E.I.L.P.A.M.S.V.P. Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report // Eur Rev Med Pharmacol Sci. 2024.
Von Und Zu Fraunberg M. et al. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria // Medicine. Medicine (Baltimore), 2005. Vol. 84, № 1. P. 35–47.
Tracy J.A., James P., Dyck B. Porphyria and its neurologic manifestations. 2014.
Pischik E. et al. Pathogenesis of acute encephalopathy in acute hepatic porphyria // J Neurol. 2023. Vol. 270, № 5.
Stölzel U., Doss M.O., Schuppan D. Clinical Guide and Update on Porphyrias // Gastroenterology. 2019.
Jiao C. et al. Acute intermittent porphyria complicated with acute pancreatitis: A case report and literature review // Medicine (United States). 2023. Vol. 102, № 46.
Laiwah A.C.Y. et al. Autonomic neuropathy in acute intermittent porphyria // J Neurol Neurosurg Psychiatry. 1985. Vol. 48, № 10.
Oomman A., Gurtoo A. Acute Intermittent Porphyria as a Cause of Acute Respiratory Failure // J Indian Med Assoc. 2002.
Watson C.J. et al. Use of hematin in the acute attack of the “inducible” hepatic prophyrias // Adv Intern Med. 1978. Vol. 23. P. 265–286.
Anderson K.E., Collins S. Open-Label Study of Hemin for Acute Porphyria: Clinical Practice Implications // American Journal of Medicine. Am J Med, 2006. Vol. 119, № 9.
Herrick A.L. et al. CONTROLLED TRIAL OF HAEM ARGINATE IN ACUTE HEPATIC PORPHYRIA // The Lancet. Lancet, 1989. Vol. 333, № 8650. P. 1295–1297.
Tschudy D.P. et al. The effect of carbohydrate feeding on the induction of δ-aminolevulinic acid synthetase // Metabolism. Metabolism, 1964. Vol. 13, № 5. P. 396–406.
Handschin C. et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1α // Cell. Cell, 2005. Vol. 122, № 4. P. 505–515.
Anderson K.E. Acute hepatic porphyrias: Current diagnosis & management // Molecular Genetics and Metabolism. 2019.
Яцков К.В. et al. Интенсивная терапия осложнений острой порфирии // Анестезиология и реаниматология. 2015. Vol. 60. P. 37–42.
Kauppinen R., Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases // Medicine (Baltimore). 1992. Vol. 71, № 1. P. 1–13.
Hift R.J., Thunell S., Brun A. Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity // Pharmacology and Therapeutics. Elsevier Inc., 2011. Vol. 132, № 2. P. 158–169.
Kazamel M., Pischik E., Desnick R.J. Pain in acute hepatic porphyrias: Updates on pathophysiology and management // Frontiers in Neurology. 2022. Vol. 13.
Пустовойт Я.С. и др. Дифференцированные подходы к интенсивной терапии больных с тяжелым течением острой порфирии // Анестезиология и реаниматология. 2009. Vol. 2. P. 39–45.
Pischik E. et al. Clinical features predictive of a poor prognosis in acute porphyria [9] // Journal of Neurology. 2004. Vol. 251, № 12.
Супонева Н. П.М.А., С.Н.Н. Синдром Гийена-Барре. Клинические рекомендации. Москва: Горячая линия - Телеком, 2018.
Белкин А.А. и др. Под ред. И.Б. Заболотских Е.М.Шифмана. Реабилитация в интенсивной терапии. Клинические рекомендации. Анестезиология-реаниматология. 2016. 858–913 p.
Innala E. et al. Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria // Acta Obstet Gynecol Scand. 2010.
Andersson C., Innala E., Bäckström T. Acute intermittent porphyria in women: Clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden // J Intern Med. 2003.
De Block C.E.M., De Leeuw I.H., Van Gaal L.F. Premenstrual attacks of acute intermittent porphyria: Hormonal and metabolic aspects - A case report // Eur J Endocrinol. 1999.
Yarra P. et al. Benefits of prophylactic heme therapy in severe acute intermittent porphyria // Mol Genet Metab Rep. Elsevier Inc., 2019. Vol. 19.
Naik H. et al. Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study // Mol Genet Metab. Academic Press Inc., 2016. Vol. 119, № 3. P. 278–283.
Singal A.K. et al. Liver transplantation in the management of porphyria // Hepatology. John Wiley and Sons Inc., 2014. Vol. 60, № 3. P. 1082–1089.
Badminton M.N., Deybach J.-C. Treatment of an acute attack of porphyria during pregnancy // Eur J Neurol. 2006. Vol. 13, № 6. P. 668–669.
Marsden J.T., Rees D.C. A retrospective analysis of outcome of pregnancy in patients with acute porphyria // J Inherit Metab Dis. J Inherit Metab Dis, 2010. Vol. 33, № 5. P. 591–596.
Pischik E., Kauppinen R. Can pregnancy stop cyclical attacks of porphyria? // American Journal of Medicine. Elsevier Inc., 2006. Vol. 119, № 1. P. 88–90.
Mirralles A.M.B., Torres-Castro R., Guzman C.O. A Comprehensive Rehabilitation Program and Follow-up Assessment for Acute Intermittent Porphyria // Am J Phys Med Rehabil. Lippincott Williams and Wilkins, 2017. Vol. 96, № 5. P. e85–e88.
Innala E., Andersson C. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden // J Intern Med. John Wiley & Sons, Ltd, 2011. Vol. 269, № 5. P. 538–545.
Pischik E L.M.P.N.K.R. Long-term complications in acute porphyria // Liver Int. 2024.
Haefeli M., Elfering A. Pain assessment // European Spine Journal. Springer, 2006. Vol. 15, № SUPPL. 1. P. S17.